May 13, 2013 — A new method of dynamic, personalized intravenous hydration significantly reduces the percentage of ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
April 22, 2013 — HealthTrust has awarded IRadimed Corp. a contract for its MRidium magnet resonance imaging (MRI) ...
March 21, 2013 -- Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
March 14, 2013 — Lantheus Medical Imaging Inc. announced the U.S. Food and Drug Administration (FDA) has granted ...
March 12, 2013 — Many physicians have long believed that the use of intravenous contrast agents for computed tomography ...
March 5, 2013 - Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron emission ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
February 20, 2013 — Guerbet announced that the Medical Imaging Drugs Advisory Committee to U.S. Food and Drug ...
February 7, 2013 — Performing heart surgery on the same day as angiography is now confirmed as a risk factor for acute ...
January 18, 2013 — GE Healthcare announced that it has filed a supplemental new drug application (sNDA) that will allow ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
December 4, 2012 — Bracco Diagnostics Inc. is voluntarily initiating a Class I recall of nine lots of Isovue (iopamidol ...
Like an eyewitness to a freight train bearing down on a rocket fuel truck at a railroad crossing, I couldn’t avoid ...
August 28, 2012 — The International Contrast Ultrasound Society (ICUS) applauded the U.S. Food and Drug Administration’s ...
With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...
August 28, 2012 — GE Healthcare announced important changes to the U.S. product label for Optison (perflutren protein ...
Bayer HealthCare highlighted its Certegra Total Dose Management solution to attendees at the AHRA 2012 annual meeting ...
July 31, 2012 — Bracco Diagnostics Inc., the U.S.-based company of the Bracco Group, announced that the U.S. Food and ...
When I was a kid, living in a mid-size Wisconsin town, my family would drive the mile or so from our home to the Lake ...
Frederic H. Fahey, DSc, incoming president of the Society of Nuclear Medicine and Molecular Imaging, shares his views ...
July 20, 2012 — Acusphere Inc. announced that it had completed the marketing authorization application (MAA) dossier for ...
July 13, 2012 — GE Healthcare and VPDiagnostics Inc. jointly announced today their co-marketing agreement for the ...
July 11, 2012 — Lantheus Medical Imaging Inc., a developer, manufacturer and distributor of diagnostic imaging agents ...